关闭
 
读者在线:用户名 密码
首页 期刊简介 投稿须知 期刊目录 专家风采 编委会 特邀顾问 联系我们 移动出版
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5



刊物信息

期刊名称:药物分析杂志
主管单位:中国科学技术协会
主办单位:中国药学会
承办:中国食品药品检定研究院
主编:金少鸿
地址:北京天坛西里2号
邮政编码:100050
电话:010-67012819,67058427
电子邮箱:ywfx@nifdc.org.cn
国际标准刊号:ISSN 0254-1793
国内统一刊号:CN 11-2224/R
邮发代号:2-237
 

访问统计
您是第  1 0 2 3 0 0 6 0 位浏览者
您当前的位置:首页 >> 正文

吉九里香碱体外诱导人大肠癌HCT-15细胞凋亡的机理研究

Mechanism study on induction of apoptosis by girinimbrine in HCT-15 cell in vitro

分类号:
出版年·卷·期(页码):2011,31 (9):0-0
DOI: 10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------

目的: 探讨中药单体吉九里香碱体外诱导HCT-15细胞凋亡的分子作用机理。 方法: 采用Western Blotting、体外Bcl-xL蛋白竞争结合检测实验及RT-PCR对吉九里香碱诱导细胞凋亡的机制进行研究。 结果: 结果显示50 μmol·L-1吉九里香碱分别作用HCT-15细胞6 h、12 h及24 h,P53蛋白表达水平基本没有变化;Cyto c呈时效性的从线粒体释放到胞质中,Bcl-2蛋白表达基本没有变化,Bcl-xL的表达被抑制在较低水平,吉九里香碱处理细胞6 h后Bax表达开始增加,Bax与Bcl-xL蛋白表达的相对比例上调;与死亡受体通路中相关的FADD表达未见异常,同时线粒体通路中的蛋白包括Caspase-7、Caspase-8、Caspase-9、Caspase-3等均没有被剪切,但相应的凋亡标志物PARP和Rb等以时间依赖形式被剪切;RT-PCR检测结果显示Bcl-2的mRNA水平基本不变,而Bax的mRNA水平随时间的增加而略有增加,说明吉九里香碱从基因水平影响Bax靶基因的转录表达;另外,吉九里香碱能明显竞争BH3与Bcl-xL蛋白的结合,强度甚至强于阳性药HA14-1。 结论: 吉九里香碱诱发HCT-15细胞凋亡的分子机制在于从基因水平影响Bax靶基因的转录表达,同时通过与Bcl-xL蛋白的BH3结构域特异性结合置换出Bax蛋白以增加Bax同源二聚体的浓度,进而影响二者的蛋白表达水平比例,最终导致线粒体功能紊乱来发挥其诱导HCT-15细胞凋亡的效应,且为P53和Caspases非依赖型。

-----英文摘要:---------------------------------------------------------------------------------------

Objective: To investigate the molecular mechanism study on induction of apoptosis by Chinese medicine monomer girinimbrine in HCT-15 cell in vitro. Methods: The mechanism of apoptosis of HCT-15 cells induced by girinimbrine was investigated by Western Blotting, in vitro Bcl-xL competitive binding assay and reverse transcription-PCR(RT-PCR) assay. Results: The results showed that the expression of P53 protein did not change when HCT-15 cells was treated with 50 μmol·L-1 girinimbrine for 6, 12, 24 h, respectively; Moreover, the Cyto c was released from mitochondria into the cytosol in a time-dependent manner. The expression of Bcl-2 protein kept unchangable and the expression of Bcl-xL has been suppressed to a lower level, therefore while Bax began to increase at 6 h after the treatment of girinimbrine, the ratio of Bax/Bcl-xL expression was up-regulated. But the expression of proteins related to death receptor such as FADD, Caspase-8 maintained invariable, and the proteins of mitochondrial pathways including Caspase-7, Caspase-9 and Caspase-3 were not cleaved, whereas PARP and Rb which are relevant key substrates for apoptosis were cleaved in a time-dependent manner. The result of RT-PCR assay indicated that the transcription level of mRNA for Bcl-2 gene was not altered and Bax gene increased slightly in HCT-15 cells treated with 50 μmol·L-1 girinimbrine for different times, revealing that Bax gene was involved in the apoptosis induced by girinimbrine but Bcl-2 was not. In addition, girinimbrine could competitively bind with Bcl-xL protein structure domain and showed stronger binding affinity than that of the positive control HA14-1. Conclusion: The molecular mechanism of girinimbrine inducing HCT-15 cells apoptosis involves in such processes as affecting the transcription level of Bax gene, binding with the Bcl-xL protein structure domain and exchanging the Bax protein by specific binding with the BH3 structural domain of Bcl-xL protein to increase the concentration of the Bax homodimers which further affect the ratio of Bax/Bcl-xL expression level and at last leading to mitochondrial dysfunction and thus to induce cell apoptosis, but not depending on P53 and Caspases of the death receptor and mitochondrial pathways.

-----参考文献:---------------------------------------------------------------------------------------

欢迎阅读《药物分析杂志》!您是该文第 1017位读者!

药物分析杂志 © 2009
地址:北京天坛西里2号 邮政编码:100050; 电子邮件:ywfx@nicpbp.org.cn